Recognizing and Managing Adverse Events in Y-90 Radioembolization
Authors:
- 7 October 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 38 (04) , 453-459
Abstract
Transarterial radioembolization using yttrium-90 (Y-90) microspheres is an important therapy in the management of unresectable primary liver tumors or hepatic metastases. While radioembolization is generally well-tolerated, it is not free from adverse events, and familiarity with the prevention and treatment of radioembolization-specific complications is an important component of patient care. This article aims to review radioembolization-specific toxicities stratified by hepatic, extrahepatic, and systemic effects, with a focus on preventing and mitigating radioembolization-induced morbidity.Keywords
This publication has 42 references indexed in Scilit:
- Prognostic factors and prevention of radioembolization-induced liver diseaseHepatology, 2012
- Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage PatientsJournal of Vascular and Interventional Radiology, 2012
- Hepatic Radioembolization Complicated by Gastrointestinal UlcerationSeminars in Interventional Radiology, 2011
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Complications Following Radioembolization with Yttrium-90 Microspheres: A Comprehensive Literature ReviewJournal of Vascular and Interventional Radiology, 2009
- Treatment Parameters and Outcome in 680 Treatments of Internal Radiation With Resin 90Y-Microspheres for Unresectable Hepatic TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Radiation Dermatitis following Radioembolization for Hepatocellular Carcinoma: A Case for Prophylactic Embolization of a Patent Falciform ArteryJournal of Vascular and Interventional Radiology, 2009
- Gastrointestinal Complications Associated with Hepatic Arterial Yttrium-90 Microsphere TherapyJournal of Vascular and Interventional Radiology, 2007
- Aspects on Reducing Gastrointestinal Adverse Effects Associated with RadiotherapyActa Oncologica, 1999
- Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systemsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995